Cargando…

Comparison of two prepill cortisol concentrations in dogs with hypercortisolism treated with trilostane

BACKGROUND: The ideal method for monitoring trilostane therapy in dogs with hypercortisolism is still open to debate. Recently, determination of the pre-trilostane (prepill) cortisol concentration has been proposed to be more repeatable than either post-trilostane or post-ACTH cortisol. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boretti, Felicitas, Musella, Caterina, Burkhardt, Wanda, Kuemmerle-Fraune, Claudia, Riond, Barbara, Reusch, Claudia, Sieber-Ruckstuhl, Nadja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307252/ https://www.ncbi.nlm.nih.gov/pubmed/30591042 http://dx.doi.org/10.1186/s12917-018-1750-3

Ejemplares similares

Effects of Trilostane on urinary Catecholamines and their metabolites in dogs with Hypercortisolism
por: Sieber-Ruckstuhl, Nadja, et al.
Publicado: (2017)

Salivary cortisol in healthy dogs: a randomized cross-over study to evaluate different saliva stimulation methods and their effects on saliva volume and cortisol concentration
por: Meunier, Solène, et al.
Publicado: (2021)

Urinary Corticoid Concentrations Measured by 5 Different Immunoassays and Gas Chromatography‐Mass Spectrometry in Healthy Dogs and Dogs with Hypercortisolism at Home and in the Hospital
por: Galeandro, L., et al.
Publicado: (2014)

Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
por: Golinelli, Stefania, et al.
Publicado: (2021)

Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)

Urinary and Plasma Catecholamines and Metanephrines in Dogs with Pheochromocytoma, Hypercortisolism, Nonadrenal Disease and in Healthy Dogs
por: Salesov, E., et al.
Publicado: (2015)

Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism
por: Sieber‐Ruckstuhl, Nadia S., et al.
Publicado: (2019)

Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs
por: Macfarlane, L., et al.
Publicado: (2016)

Cortisol Response in Healthy and Diseased Dogs after Stimulation with a Depot Formulation of Synthetic ACTH
por: Sieber‐Ruckstuhl, N.S., et al.
Publicado: (2015)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Effects of ACTH-Induced Long-Term Hypercortisolism on the Transcriptome of Canine Visceral Adipose Tissue
por: Tavares Pereira, Miguel, et al.
Publicado: (2022)

Clinical features and long‐term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone
por: Sieber‐Ruckstuhl, Nadja S., et al.
Publicado: (2023)

Use of Plasma Renin Activity to Monitor Mineralocorticoid Treatment in Dogs with Primary Hypoadrenocorticism: Desoxycorticosterone Versus Fludrocortisone
por: Baumstark, M.E., et al.
Publicado: (2014)

Evaluation of Aldosterone Concentrations in Dogs with Hypoadrenocorticism
por: Baumstark, M.E., et al.
Publicado: (2013)

TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism
por: Pijnacker, Tera, et al.
Publicado: (2018)

Characterization of recombinant human and bovine thyroid-stimulating hormone preparations by mass spectrometry and determination of their endotoxin content
por: Schaefer, Sandra, et al.
Publicado: (2013)

Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment
por: Reusch, C.E., et al.
Publicado: (2017)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

Serum lipidome analysis of healthy beagle dogs receiving different diets
por: Boretti, Felicitas S., et al.
Publicado: (2019)

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Reduced cortisol metabolism drives hypercortisolism in critical illness
por: Boonen, E, et al.
Publicado: (2012)

Serum Lipidome Signatures of Dogs with Different Endocrinopathies Associated with Hyperlipidemia
por: Sieber-Ruckstuhl, Nadja S., et al.
Publicado: (2022)

Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release
por: Krämer, Anna L., et al.
Publicado: (2020)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

Correlation of plasma coagulation tests and fibrinogen(Clauss) with rotational thromboelastometry parameters and prediction of bleeding in dogs
por: Enk, Nathalie M., et al.
Publicado: (2018)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism
por: Tinted, Nannicha, et al.
Publicado: (2023)

The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism
por: Berndt, Vendela, et al.
Publicado: (2022)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Possible Therapeutic Effect of Trilostane in Rodent Models of Inflammation and Nociception()
por: Tung, David, et al.
Publicado: (2013)

Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism
por: Corsini, Andrea, et al.
Publicado: (2021)

Long‐Term Survival of Dogs with Adrenal‐Dependent Hyperadrenocorticism: A Comparison between Mitotane and Twice Daily Trilostane Treatment
por: Arenas, C., et al.
Publicado: (2014)

Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
por: Nagata, N., et al.
Publicado: (2016)

Tissue Doppler and strain imaging of left ventricle in Beagle dogs with iatrogenic hypercortisolism
por: Oui, Heejin, et al.
Publicado: (2015)

Concurrent pituitary and adrenocortical lesions on computed tomography imaging in dogs with spontaneous hypercortisolism
por: van Bokhorst, Kirsten L., et al.
Publicado: (2018)

Isolated hypoaldosteronism managed by DOCP in a dog with chronic kidney disease and hypercortisolism
por: Park, Su‐Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2f53ju9lk36pnsi0s9pv9duqqp